Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

GBD 2021 NERVOUS SYSTEM DISORDERS COLLABORATORS, (2024). Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. Neurology, 23 (4), 344-381.

Preview

PDF Khatab-GlobalRegionalAndNational2021(VoR).pdf - Published Version Publisher specific licence - see copyright information. Download (729kB) | Preview

Abstract

Background

Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.

Methods

We estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.

Findings

Globally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378-521), affecting 3·40 billion (3·20-3·62) individuals (43·1%, 40·5-45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7-26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6-38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5-32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7-2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.

Interpretation

As the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed.

Funding

Bill & Melinda Gates Foundation.

Item Type:	Article
Contributors:	Khatab, Khaled [0000-0002-8755-3964] (Affiliation: Sheffield Hallam University)
Uncontrolled Keywords:	GBD 2021 Nervous System Disorders Collaborators; Humans; Communicable Diseases; Diabetic Neuropathies; Premature Birth; Disease Progression; Life Expectancy; Risk Factors; Quality-Adjusted Life Years; Infant, Newborn; Female; Global Health; Autism Spectrum Disorder; Zika Virus; Zika Virus Infection; Global Burden of Disease; COVID-19; Female; Humans; Infant, Newborn; Global Burden of Disease; Diabetic Neuropathies; Autism Spectrum Disorder; Premature Birth; Communicable Diseases; Risk Factors; Disease Progression; Global Health; COVID-19; Zika Virus; Zika Virus Infection; Quality-Adjusted Life Years; Life Expectancy; 1103 Clinical Sciences; 1109 Neurosciences; Neurology & Neurosurgery; 3202 Clinical sciences; 3209 Neurosciences
Identification Number:	https://doi.org/10.1016/s1474-4422(24)00038-3
Page Range:	344-381
SWORD Depositor:	Symplectic Elements
Depositing User:	Symplectic Elements
Date Deposited:	07 Jun 2024 13:54
Last Modified:	08 Jun 2024 02:01
URI:	https://shura.shu.ac.uk/id/eprint/33801

Actions (login required)

View Item

Downloads

Publication Metrics